Lette J, Waters D, Bernier H, Champagne P, Lassonde J, Picard M, Cerino M, Nattel S, Boucher Y, Heyen F
Department of Medicine, Maisonneuve Hospital, Montreal, Quebec, Canada.
Ann Surg. 1992 Aug;216(2):192-204. doi: 10.1097/00000658-199208000-00010.
A total of 360 patients underwent preoperative cardiac risk assessment using 23 clinical parameters, seven multivariate clinical scoring systems, and quantitative dipyridamole-thallium imaging to predict postoperative and long-term myocardial infarction and cardiac death after noncardiac surgery. There were 30 postoperative and an additional 13 cumulative long-term cardiac events after an average follow-up of 15 months. Clinical descriptors were not useful in predicting the outcome of individual patients. The postoperative and long-term cardiac event rates were 1% and 3.5%, respectively, in patients with normal scans or fixed perfusion defects, and 17.5% and 22% in patients with reversible defects. Using quantitative indices reflecting the amount of jeopardized myocardium, patients could be stratified by dipyridamole imaging into multiple scintigraphic subsets, with corresponding postoperative and 1-year coronary morbidity and mortality rates ranging from 0.5% to 100% (p = 0.0001). Thus, postoperative and long-term cardiac events cannot be predicted clinically, whereas quantitative dipyridamole imaging accurately identifies high-risk patients who require preoperative coronary angiography.
共有360例患者接受了术前心脏风险评估,评估采用了23项临床参数、7种多变量临床评分系统以及双嘧达莫-铊定量心肌灌注显像,以预测非心脏手术后的近期及远期心肌梗死和心脏死亡情况。平均随访15个月后,出现了30例术后心脏事件以及另外13例累积远期心脏事件。临床指标对预测个体患者的预后并无帮助。扫描结果正常或存在固定灌注缺损的患者,术后及远期心脏事件发生率分别为1%和3.5%,而存在可逆性缺损的患者这一发生率分别为17.5%和22%。利用反映心肌危险程度的定量指标,通过双嘧达莫显像可将患者分为多个闪烁照相亚组,相应的术后及1年冠状动脉发病率和死亡率在0.5%至100%之间(p = 0.0001)。因此,无法通过临床方法预测术后及远期心脏事件,而双嘧达莫定量显像能够准确识别需要术前进行冠状动脉造影的高危患者。